Pegylated interferon plus ribavirin in HIV-infected patients with recurrent hepatitis C after liver transplantation: a prospective cohort study.

The complete genome sequence of New World jatropha mosaic virus.

HCV-induced immune responses influence the development of operational tolerance after liver transplantation in humans.

Professional recognition of female and male doctors.

Interferon-free regimens in the liver-transplant setting.

Liver stiffness 1 year after transplantation predicts clinical outcomes in patients with recurrent hepatitis C.

Prospective multicenter clinical trial of immunosuppressive drug withdrawal in stable adult liver transplant recipients.

Immunosuppression minimization vs. complete drug withdrawal in liver transplantation.

Pretransplant and posttransplant treatment of hepatitis C virus infection with protease inhibitors.

Interferon free regimens for the "difficult-to-treat": are we there?

Prescribing patterns and economic costs of proton pump inhibitors in Colombia.

A need for biomarkers of operational tolerance in liver and kidney transplantation.

An acidic phospholipase A₂ with antibacterial activity from Porthidium nasutum snake venom.

Can we predict allograft tolerance in experimental animal models of transplantation?

Intra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantation.